1. New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an "ESMO Open – Cancer Horizons" Series. (12th June 2019) Authors: Lambertini, Matteo; Preusser, Matthias; Zielinski, Christoph C Journal: ESMO open Issue: Volume 4(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Introducing a new ESMO Open article series: how I treat side effects of immunotherapy. (5th July 2019) Authors: Preusser, Matthias Journal: ESMO open Issue: Volume 4(2020)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Author response to Cunha et al. Issue 7 (27th July 2021) Authors: Colen, Rivka R; Rolfo, Christian; Ak, Murat; Ayoub, Mira; Ahmed, Sara; Elshafeey, Nabil; Mamindla, Priyadarshini; Zinn, Pascal O; Ng, Chaan; Vikram, Raghu; Bakas, Spyridon; Peterson, Christine B; Rodon Ahnert, Jordi; Subbiah, Vivek; Karp, Daniel D; Stephen, Bettzy; Hajjar, Joud; Naing, Aung Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers. Issue 7 (27th July 2021) Authors: Cunha, Mateus Trinconi; Carvalho, Vinicius Jardim; Loureiro, Rafael Maffei; Brantis-de-Carvalho, Carlos Eduardo; Cintra, Murilo Bicudo; de Castro Junior, Gilberto Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Mac Cheever (1944–2021): a tribute to a life of achievement and service. Issue 1 (12th January 2022) Authors: Greenberg, Philip D; Disis, Mary L; Margolin, Kim A; Matrisian, Lynn M; Sondel, Paul M Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better. Issue 1 (31st January 2022) Authors: Zheng, Ming Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. Issue 1 (19th January 2021) Authors: Rogiers, Aljosja; Pires da Silva, Ines; Tentori, Chiara; Tondini, Carlo Alberto; Grimes, Joseph M; Trager, Megan H; Nahm, Sharon; Zubiri, Leyre; Manos, Michael; Bowling, Peter; Elkrief, Arielle; Papneja, Neha; Vitale, Maria Grazia; Rose, April A N; Borgers, Jessica S W; Roy, Severine; Mangana, Jo... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study. Issue 4 (13th April 2021) Authors: Lee, Meghan D; Seethapathy, Harish; Strohbehn, Ian A; Zhao, Sophia H; Boland, Genevieve M; Fadden, Riley; Sullivan, Ryan; Reynolds, Kerry L; Sise, Meghan E Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation. Issue 2 (19th October 2020) Authors: Cortellini, Alessio; Ricciuti, Biagio; Tiseo, Marcello; Bria, Emilio; Banna, Giuseppe L; Aerts, Joachim GJV; Barbieri, Fausto; Giusti, Raffaele; Cortinovis, Diego L; Migliorino, Maria R; Catino, Annamaria; Passiglia, Francesco; Torniai, Mariangela; Morabito, Alessandro; Genova, Carlo; Mazzoni, Fr... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗